BartolomeBurgueraMD
Endocrinology • Cleveland, OHDiabetes, Lipid Metabolism
Director of Obesity Programs Endocrinology Institute Cleveland Clinic
Dr. Burguera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland Clinic. Department Of Endocrinology
Cleveland, OH 44195Phone+1 216-445-8645
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 1999
Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 1994 - 1996
Pontificia Universidad Catolica de ChileClass of 1986
Certifications & Licensure
OH State Medical License 2013 - 2025
PA State Medical License 2000 - 2004
MN State Medical License 1996 - 2001
Publications & Presentations
PubMed
- De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: ...Paloma Rodriguez, Nikki Breslaw, Huijun Xiao, Jim Bena, Kimberly Jenkins
Diabetes, Obesity & Metabolism. 2024-11-12 - Effective but inaccessible antiobesity medications: A call for sharing responsibility for improving access to evidence-based care.Bartolome Burguera, Marcio L Griebeler, W Timothy Garvey
Cleveland Clinic Journal of Medicine. 2024-11-01 - Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes.Anukriti Sharma, Arshiya Mariam, Emily Zacherle, Alex Milinovich, Janine Bauman
Diabetes, Obesity & Metabolism. 2024-11-01
Press Mentions
Study Shows Bariatric Surgery Provides Superior Long-Term Treatment for Type 2 Diabetes in Patients with ObesityFebruary 27th, 2024- Long COVID-19 Among Patients with Obesity ‘May Be Missed or Misdiagnosed’September 17th, 2021
- Access to Obesity Medications Boosts Weight Loss in Employer-Based ProgramAugust 4th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
